Akero Therapeutics, Inc. (AKRO) Net Income by Year
Akero Therapeutics, Inc. reported a net loss of $252.1M in fiscal year 2024. This represents a decrease of 66.1% from the prior fiscal year. The table below carries 7 fiscal years, from 2018 to 2024, and the quarters Akero Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AKRO Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
AKRO Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Akero Therapeutics, Inc. financials
Frequently Asked Questions
What was Akero Therapeutics, Inc.'s net income in fiscal year 2024?
Akero Therapeutics, Inc. reported a net loss of $252.1M in fiscal year 2024.
How fast is Akero Therapeutics, Inc.'s net income growing?
Akero Therapeutics, Inc. (AKRO) net income fell by 66.1% year over year, from -$151.8M to -$252.1M in fiscal year 2024.
How has Akero Therapeutics, Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, Akero Therapeutics, Inc. (AKRO) net income went from -$81.7M in fiscal year 2018 to -$252.1M in fiscal year 2024.
What was Akero Therapeutics, Inc.'s net income in the most recent quarter?
Akero Therapeutics, Inc. (AKRO) reported -$81.6M in net income in Q3 2025. This represents a decrease of 12.2% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Akero Therapeutics, Inc. (AKRO) reported on that line in every period on record.